(136 days)
Not Found
No
The device description focuses on mechanical components and vacuum pressure, with no mention of AI/ML or related concepts.
Yes
The device is described as a "Vacuum Curettage System" used for "rapid transcervical aspiration of the uterine cavity" to "remove uterine contents." This function directly treats a medical condition (e.g., incomplete miscarriage, elective abortion, removal of retained placental tissue), making it a therapeutic device.
No
The device is described as a system for "rapid transcervical aspiration of the uterine cavity" to "remove uterine contents through the cervix." This indicates a therapeutic or procedural function, not a diagnostic one.
No
The device description clearly outlines multiple hardware components including a vacuum pump, collection containers, tubing, vacurettes, a stainless steel cabinet, and a foot actuator pedal. It is a physical system, not software only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "For rapid transcervical aspiration of the uterine cavity." This describes a procedure performed directly on the patient's body to remove contents.
- Device Description: The device is a vacuum system designed to physically remove uterine contents. It includes a pump, collection containers, tubing, and vacurettes.
- Lack of Diagnostic Purpose: There is no mention of the device being used to analyze samples in vitro (outside the body) for diagnostic purposes. The focus is on the physical removal of tissue.
- Anatomical Site: The anatomical site is the "Uterine cavity," indicating a direct interaction with the patient's body.
IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnostic, monitoring, or compatibility purposes. This device's function is purely procedural and not for in vitro analysis.
N/A
Intended Use / Indications for Use
For rapid transcervical aspiration of the uterine cavity.
Product codes
HHI, HHK
Device Description
The Berkeley VC-10 Vacuum Curettage System uses aspiration to remove uterine contents through the cervix. The system includes the vacuum pump, collection containers, connection tubing, and patient contacting vacurettes. The vacuum pump is electrically powered and generates suction through vacuum pressure. The vacuum pump console is not provided sterile and is a multi-use device. The patient contacting vacurettes of the VC-10 system are provided as sterile, single use disposable devices.
Similar to the predicate device VC-10, the modified Berkeley VC-10 includes a high capacity. double diaphragm pump and motor, enclosed in a stainless steel cabinet. Collection canisters sit on top of the cabinet, and a large vacuum gauge and vacuum control knob are easily accessed on the top of the cabinet. A vacurette (available in various shapes and sizes) is attached to a collection set (includes a plastic swivel handle with a slip ring to control the vacuum and PVC tubing) and is attached to the patient port of the first collection container. Two accessories, which can be used to collect tissue, include a tissue trap, which is connected to the collection tubing and the collection container, or a gauze sack, which is placed inside the collection container. The modified VC-10 offers the same foot actuator pedal for vacuum supply.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
uterine cavity
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The following bench performance tests were conducted to assess the functional performance of the modified device:
- Maximum Measured Vacuum Pressure
- Free Flow Rate
- Time to Develop Vacuum
- Time to Reach Full Vacuum
- Time to Evacuate 1L w/ 7mm Curette
- Time to Evacuate 1L w/ 6mm Curette
All performance testing passed or met the pre-specified acceptance criteria.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.5070 Vacuum abortion system.
(a)
Identification. A vacuum abortion system is a device designed to aspirate transcervically the products of conception or menstruation from the uterus by using a cannula connected to a suction source. This device is used for pregnancy termination or menstrual regulation. This type of device may include aspiration cannula, vacuum source, and vacuum controller.(b)
Classification. Class II (performance standards).
0
Public Health Service
Image /page/0/Picture/2 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle with three human profiles incorporated into its design.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 29, 2017
Gyrus ACMI, Inc. Christina Flores Senior Specialist, Regulatory Affairs 136 Turnpike Road Southborough, MA 01772
Re: K171440
Trade/Device Name: Berkeley VC-10 Vacuum Curettage System Regulation Number: 21 CFR& 884.5070 Regulation Name: Vacuum Abortion System Regulatory Class: II Product Code: HHI, HHK Dated: August 31, 2017 Received: September 1, 2017
Dear Christina Flores:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
1
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Charles Viviano -S
For Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K171440
Device Name Berkeley VC-10 Vacuum Curettage System
Indications for Use (Describe) For rapid transcervical aspiration of the uterine cavity.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
__ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
K171440
510(k) Summary Gyrus ACMI, Inc. Berkeley VC-10 Vacuum Curettage System
General Information
| 510(k) Submitter | Gyrus ACMI, Inc. 136 Turnpike Rd Southborough, MA 01772 Phone: 508-804-2776 |
|---|---|
| Establishment Registration Number: | 3003790304 |
| Contact Person: | Christina Flores Senior Specialist, Regulatory Affairs 508-804-2776 Christina.flores@olympus-osta.com |
| Date Prepared: | September 27, 2017 |
Device Identification
| Classification Name: | Vacuum Abortion System |
|---|---|
| Regulation number | 21 CFR 884.5070 |
| Product codes | HHI (System, Abortion, Vacuum) HHK (Curette, Suction, Endometrial (And Accessories)) |
| Regulatory Class | Class II |
| Trade Name: | Berkeley VC-10 Vacuum Curettage System |
| Generic/Common Name: | Vacuum abortion system |
Predicate Device
| K030935 | Gyrus ACMI VC-10 |
|---|---|
| --------- | ------------------ |
The predicate device has not been subject to a design-related recall.
Product Description
The Berkeley VC-10 Vacuum Curettage System uses aspiration to remove uterine contents through the cervix. The system includes the vacuum pump, collection containers, connection tubing, and patient contacting vacurettes. The vacuum pump
4
is electrically powered and generates suction through vacuum pressure. The vacuum pump console is not provided sterile and is a multi-use device. The patient contacting vacurettes of the VC-10 system are provided as sterile, single use disposable devices.
Similar to the predicate device VC-10, the modified Berkeley VC-10 includes a high capacity. double diaphragm pump and motor, enclosed in a stainless steel cabinet. Collection canisters sit on top of the cabinet, and a large vacuum gauge and vacuum control knob are easily accessed on the top of the cabinet. A vacurette (available in various shapes and sizes) is attached to a collection set (includes a plastic swivel handle with a slip ring to control the vacuum and PVC tubing) and is attached to the patient port of the first collection container. Two accessories, which can be used to collect tissue, include a tissue trap, which is connected to the collection tubing and the collection container, or a gauze sack, which is placed inside the collection container. The modified VC-10 offers the same foot actuator pedal for vacuum supply.
Indications for Use
For rapid transcervical aspiration of the uterine cavity.
The indications for use and intended use of the modified/unmodified Berkeley VC-10 Vacuum Curettage System has not changed as a result of the vacuum pump motor modification in this submission. The indications for use of the subject and predicate devices are identical.
Comparison to Predicate Device:
The modified Berkeley VC-10 has been compared to the predicate VC-10 device with respect to intended use, design, performance, and fundamental scientific technology.
The Berkeley VC-10 was originally cleared in K030935. The modification that is the subject of this submission is to the vacuum pump and motor in the console of the Berkeley VC-10 Vacuum Curettage System. The horsepower rating for the predicate and new vacuum pump is changing from 1/3 horsepower to 1/2 horsepower. All other components of the system are identical to those cleared in K030935. The system's interface with the disposable components has not changed with this modification.
No changes were made to patient contacting material or packaging to the modified VC-10 since the predicate system was cleared in K030935.
A comparison of the pump specifications for the modified Berkeley VC-10 system and the predicate Berkeley VC-10 system is shown in the table below:
5
| VC-10 (K030935) | VC-10 (this submission) | |
|---|---|---|
| Motor part number | 72R547-V116-D303X | 87R647-101-N470X |
| Voltage/Frequency | 115VAC/60 Hz | Same |
| Power/Amps | 600VA/5A | 500VA/T6.3AH |
| Horsepower | 1/3 HP | 1/2 HP |
| Maximum Vacuum | 73 cm Hg | 71 cm Hg |
Except for the replacement of a the vacuum pump motor and the adjustments made to the internal enclosure to accommodate the new vacuum pump motor, the modified Berkeley VC-10 system and unmodified Berkeley VC-10 are identical. These minor differences do not raise different questions of safety or effectiveness. As demonstrated in the non-clinical testing (e.g., electrical safety, EMC, and functional testing), the different technological characteristics do not affect the safety and effectiveness of the subject devices. The comparisons and summary of testing results presented in this Special 510(k) Notification show this device to be substantially equivalent to the predicate VC-10 device.
Summary of Biocompatibility, Sterilization and Shelf Life Discussion
The subject of the modification is the pump motor in the non-patient contacting console of the VC-10 system. The sterile, single use disposable devices that were cleared with the system under K030935 have not been modified since receiving FDA clearance. Therefore, the current submission relies on the biocompatibility, sterilization and shelf life information provided in K030935.
Electrical Safety and Electromagnetic Compatibility (EMC)
Electrical Safety was tested according to AAMI/ANSI ES 60601-1:2005/(R) 2012 and A1:2012.
EMC was tested according to IEC 60601-1-2 Edition 3: 2007-03.
Summary of Bench. Performance Testing
The following bench performance tests were conducted to assess the functional performance of the modified device:
- Maximum Measured Vacuum Pressure ●
- Free Flow Rate
- Time to Develop Vacuum
- Time to Reach Full Vacuum ●
6
- Time to Evacuate 1L w/ 7mm Curette .
- . Time to Evacuate 1L w/ 6mm Curette
All performance testing passed or met the pre-specified acceptance criteria.
Conclusion
The modified Berkeley VC-10 has the same intended use, fundamental technology and similar design as its predicate VC-10 device. The technological differences do not raise different questions of safety or effectiveness and the performance testing demonstrates substantial equivalence.